262 results on '"Gnecchi, M"'
Search Results
2. C23 ELECTROCARDIOGRAPHIC PREDICTORS OF PRIMARY VENTRICULAR FIBRILLATION DURING A FIRST ACUTE MYOCARDIAL INFARCTION
3. C2 DIFFERENT CLINICAL PREDICTORS OF EARLY AND LATE PRIMARY VENTRICULAR FIBRILLATION: RESULTS OF THE PREDESTINATION STUDY
4. iPSC: BIOBANKING SOMATIC AND INDUCED PLURIPOTENT STEM CELLS FROM PATIENTS AFFECTED BY INHERITED CARDIAC DISEASES
5. Exosomes/EVs: COMPARISON OF CYTOPROTECTIVE AND PRO-ANGIOGENIC PROPERTIES BETWEEN WHOLE SECRETOME AND EXOSOMES DERIVED FROM HUMAN AMNIOTIC MESENCHYMAL STEM CELLS (HAMSCS)
6. Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study
7. P182 VALSARTAN LIMITS PULMONARY AND CARDIAC DAMAGE INDUCED BY SARS–COV–2 IN EXPERIMENTAL MODELS BY REDUCING THE EXPRESSION OF ACE2
8. From novel discovery tools and biomarkers to precision medicine-basic cardiovascular science highlights of 2021/22
9. Prognostic impact of achieving LDL cholesterol guidelines-recommended target in secondary prevention: a real-world study
10. Clinical utility of the academic research consortium new proposed criteria for high bleeding risk definition in patients with acute coronary syndromes
11. Usefulness of X-Ray in the Detection of Complications and Side Effects After Laparoscopic Sleeve Gastrectomy
12. GENDER DIFFERENCES IN PREDICTORS OF PRIMARY VENTRICULAR FIBRILLATION: RESULTS OF THE PREDESTINATION STUDY
13. D-dimer for the prediction of left atrial appendage thrombosis: daydream or reality? A meta-analysis
14. P376Prognostic impact of atrial fibrillation in STEMI patients treated by primary percutaneous coronary intervention: a focus on cardiogenic shock
15. P569Efficacy and safety of direct Xa oral inhibitors versus warfarin in patients with atrial fibrillation and cancer: a meta-analysis of randomized controlled trials
16. How do Extracellular Vesicles Protect the Ischemic Myocardium?
17. P1763Derivation and validation of a risk score to predict incomplete ST segment resolution in STEMI patients undergoing primary PCI: association with the benefit of Glycoprotein IIb-IIIa inhibitors Use
18. P6395Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percu
19. P1646Do Extracellular Vesicles repair chronic ischemic heart disease by replenishing the cardiomyocyte pool?
20. P5733IABP use in patients with STEMI complicated by cardiogenic shock: time for rehabilitation?
21. P2728Identification of clinical and laboratory predictors of incomplete ST segment resolution in patients undergoing primary percutaneous intervention for ST elevation myocardial infarction
22. P1679Acute glycaemia in non diabetic patients with ST elevation myocardial infarction: could it be a direct mediator of myocardial damage?
23. P3484The acute inflammatory response in elderly STEMI patients leads to greater microvascular dysfunction? A new perspective on inflammaging
24. P6399The obesity paradox in STEMI patients treated with primary PCI: is it a matter of sex?
25. 2166STEMI in women undergoing primary PCI: time to make a (gender) difference
26. P6366The use of intra-aortic balloon pump in a large population of STEMI patients treated by primary percutaneous coronary intervention
27. I disturbi del sonno: il Progetto 'Ci piace sognare'
28. P1067The prognostic impact of bleeding in STEMI patients treated by primary PCI depends on Killip class at presentation
29. P5544Inflammation, microvascular dysfunction and smoker's paradox in ST elevation myocardial infarction patients
30. The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by long QT syndrome type 2
31. Symptomatic and Asymptomatic Discrimination by Single Nucleotide Polymorphisms in LQTS2 Patients: A DNA-Based Patient Stratification
32. Modeling Heart Failure in Danon Disease Using Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes
33. Donor Age Impairs the Capacity of Human Mesenchymal Stromal Cells to Repair Cardiac and Renal Damage
34. Improving the Cardioprotective and Regenerative Properties of Bone Marrow Derived Mesenchymal Stem Cells Through the Overexpression of IGF1 and BMP2
35. Optimized Method to Determine Infarct Size and Stem Cell Engraftment in Rodent Hearts Subjected to Ischemia-Reperfusion Injury
36. Concomitant Overexpression of TGFβ1 and FGF2 in Human Bone Marrow Derived-Mesenchymal Stem Cells Improves Cell Survival and Angiogenesis
37. PROGETTO DI PREVENZIONE DELL’OBESITà INFANTILE TRA 0 E 6 ANNI 'MI VOGLIO BENE'
38. 258 - The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by long QT syndrome type 2
39. 248 - Symptomatic and Asymptomatic Discrimination by Single Nucleotide Polymorphisms in LQTS2 Patients: A DNA-Based Patient Stratification
40. 150 - Improving the Cardioprotective and Regenerative Properties of Bone Marrow Derived Mesenchymal Stem Cells Through the Overexpression of IGF1 and BMP2
41. 155 - Concomitant Overexpression of TGFβ1 and FGF2 in Human Bone Marrow Derived-Mesenchymal Stem Cells Improves Cell Survival and Angiogenesis
42. 147 - Optimized Method to Determine Infarct Size and Stem Cell Engraftment in Rodent Hearts Subjected to Ischemia-Reperfusion Injury
43. 29 - Donor Age Impairs the Capacity of Human Mesenchymal Stromal Cells to Repair Cardiac and Renal Damage
44. 18 - Modeling Heart Failure in Danon Disease Using Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes
45. Amyloidogenic light chains induce human cardiac fibroblast toxicity through alteration of mitochondrial functionality
46. Novel IRES-based lentivirus co-expressing IGF1 and BMP2 enhances both cardiomyogenesis and cytoprotection of bone marrow-derived mesenchymal stem cells
47. Pentraxin-3 and galectin-1 are key mediators of the cardioprotective paracrine effects exerted by fetal mesenchymal stem cells isolated from human placenta
48. MicroRNA133 and microRNA499 exert synergistic effect on cardiac differentiation
49. Overexpression of growth factors to improve cardiac differentiation of human mesenchymal stem cells derived from the amniotic membrane
50. Outcome of nasopharyngeal cancer treatment with radiotherapy and radiochemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.